Introduction
With the increase in overweight and obesity in the world, nonalcoholic fatty liver disease (NAFLD) has become a serious public health problem during childhood. In the pediatric population, the incidence of NAFLD was reported to be 2.6%, but this ratio in obese children has increased and ranges from 20 to 50% [1] .
NAFLD is a complex metabolic condition in which both lifestyle and genetic factors play a pathogenic role and has been increasingly recognized as a major cause of liverrelated morbidity and mortality. Moreover, NAFLD has been convincingly associated with metabolic syndrome and insulin resistance (IR) [2] .
Potential steps involved in the pathogenesis of NAFLD include abnormalities of lipid metabolism, production of reactive oxygen species, increased hepatic lipid peroxidation, activated stellate cells, and abnormal patterns of cytokine production [3] .
Bonet et al. [4] stated that in obese children IR is associated with plasma lipid alterations suggestive of both decreased adipose tissue lipolysis and hepatic b-oxidation and increased hepatic synthesis of triglycerides (TGs). Such a metabolic condition may facilitate fat storage and hinder weight loss.
NAFLD is usually asymptomatic in children. On physical examination, the liver might be slightly enlarged.
Diagnosis of NAFLD is usually made by accidental finding of mild elevation in liver tests during a routine blood test or by liver ultrasonography (US) in an overweight or obese child. In the absence of liver biopsy, presumed nonalcoholic steatohepatitis (NASH) is conventionally diagnosed by US, together with elevated serum alanine aminotransferase (ALT) levels as a marker of liver inflammation and injury [5] .
Leptin is an adipocyte-derived hormone that regulates food intake and energy expenditure by interacting with receptors in the hypothalamus. It is believed that leptin may contribute to or enhance hepatic steatosis by changing the actions of insulin on tissues and its receptors, and it may influence the development of NASH by regulating inflammatory responses [6] .
Adiponectin increases the transport of fatty acids into the mitrochondria for b-oxidation and hepatic fatty acid synthesis, thus countering the effect of high insulin. Low serum adiponectin distinguishes NASH from simple steatosis.
It was observed that adiponectin level is decreased in patients with type 2 diabetes mellitus and cardiovasular disease. Clinical trials proved that administration of adiponectin reversed steatohepatitis by combating the release of tumor necrosis factor a [7] .
This study was conducted to investigate the relationship of the presence and severity of fatty liver as detected by liver US with body mass index (BMI), hyperlipidemia, IR, serum leptin, and adiponectin.
Patients and methods

Patients
This study is a cross-sectional study carried on 25 obese children whose ages ranged from 7 to 16 years. They were randomly selected from the Pediatric Outpatient Clinic, Zagazig University Hospital, and the Ministry of Health Office. After performing liver ultrasound, they were classified according to the presence or absence of fatty liver into the following:
Group I
In this group, 15 obese children (nine boys and six girls) with fatty liver were included.
Their mean age was 12 ± 2.7 years, mean weight was 64.3 ± 14.19 kg, and mean BMI was 29.9 ± 2.5.
Group II
In this group, 10 obese children (six boys and four girls) without fatty liver were included.
Their mean age was 12.3 ± 2.2 years, mean weight was 68.6 ± 12.6 kg, and mean BMI was 27.5 ± 0.97.
All parents were informed about the purpose of this study and signed informed consent forms before blood tests were conducted.
All patients were subjected to the following:
(1) Thorough history taking.
(2) Complete physical examination: BMI was calculated as weight (kilogram) divided by the square of height (meter square) in all participants, and patients with BMI of more than 30 were considered obese according to the World Health Organization classification [8] .
(3) Laboratory investigations: Blood samples were collected from patient groups after an overnight fast, and serum samples were separated and stored at -201C until analysis.
Aspartate aminotransferase and ALT, total protein, albumin, serum cholesterol, TGs, fasting glucose levels, insulin, C-reactive protein (CRP), and complete blood count were analyzed by routine laboratory procedures. Fasting for more than 12 h was considered appropriate for correct measurement of TGs.
The homeostatic model assessment (HOMA) model was used for estimating IR.
HOMA IR (%) = fasting blood glucose (milligram/deciliter)/ 18 Â fasting insulin (micrometer/milliliter)/22.5 [9] .
Analysis of serum leptin and adiponectin
Leptin adiponectin levels were analyzed using enzymelinked immunosorbent assay kits: the leptin kit (sensitivity: 0.2 ng/ml; from DRG International Inc., USA); and the adiponectin kit (range of detection: 0.23-15 ng/ml, sensitivity: 0.1 ng/ml; from Chemicon International, Inc., USA).
(1) Liver ultrasound: Fatty liver in children was evaluated by US using a real-time scanning device -Toshiba SSA-320A, Just Vision 200 (Toshiba America Medical Systems, Tustin, CA, USA) with a convex probe of 3.5-5 mHz. US does neither differentiate fatty liver (hepatic steatosis) from steatohepatitis, nor from steatohepatitis with fibrosis. All patients who had a bright liver at ultrasound scanning (increased liver echogenicity and posterior attenuation) were considered to have fatty liver.
In this study, we used a well-recognized classification of fatty liver into mild, moderate, and severe degrees of steatosis on the basis of an increase in hepatic echogenicity, impaired visualization of hepatic vessels and diaphragm, and poor penetration of the posterior aspects of the liver [10] .
The degree of fatty infiltration in the liver was quantified by using the equation: liver echo amplitude/renal echo amplitude, whereby the hepatorenal index was defined. The hepatorenal index of normal fat-free liver is approximately 1.
In fatty liver, the severity of liver steatosis was graded as follows: grade I (mild fatty liver) was defined by a hepatorenal index of 1.5-2; grade II (moderate fatty liver) was defined as the presence of dense hyperechogenity of liver parenchyma, moderate nonhomogenous changes, punctuations and patchy hypoechoic regions with thickening of the liver edge; and grade V (severe fatty liver) was defined by a hepatorenal index of 2 or more [10] .
In this study, steatosis of group I patients was graded as mild in four cases (26.7%), moderate in four cases (26.7%), and severe in seven cases (46.6%).
The diagnosis of NAFLD was based on chronically elevated aminotransferase levels (ALT41.5 times the upper normal values for 6 months or more) and bright liver on ultrasound scanning.
Exclusion criteria
The exclusion criteria included were as follows:
(1) Presence of hepatitis B and C viral markers.
(2) Autoimmune hepatitis or celiac disease.
(3) Evidence of genetic, drug-induced, or cholestatic liver disease. (4) Renal diseases.
Statistical analysis
All analyses were carried out using the SPSS statistical software for Windows, version 11.0 (SPSS Inc., Chicago, IL, USA). Data were presented as mean ± standard deviation, unless noted as different. Difference between the groups was analyzed using the independent sample t-test. Relationships among the variables were analyzed using the Spearman's correlation test. A difference was considered significant at Po0.05. Table 1 shows the demographic characteristics of the studied individuals. There was no significant difference between the two groups with regard to age and weight, whereas there was a significant difference in relation to height and BMI. Table 2 shows the biochemical characteristics of the studied groups. Both liver enzymes, plasma insulin, HOMA, TGs, and serum leptin were significantly higher in group I relative to group II patients, whereas serum adiponectin had significantly lower values in group I compared with group II patients. Table 3 shows correlations between serum leptin adiponectin levels and BMI, cholesterol, TGs, and steatosis in group I patients. There was a highly significant positive correlation between serum leptin and BMI, cholesterol, TGs, and liver steatosis, whereas there was a highly significant negative correlation between serum adiponectin and each of these parameters.
Results
Discussion
The term nonalcoholic fatty liver disease (NAFLD) includes different liver disorders extending from simple steatosis without inflammation through NASH to fibrosis and cirrhosis [11] .
NAFLD usually develops in children who are obese. Many of these children are asymptomatic, and except for the presence of hepatomegaly the disease may be difficult to recognize. The gold standard for establishing the diagnosis and severity of NAFLD is liver biopsy, but this investigation is invasive and not frequently conducted in the pediatric population [12] .
This study was conducted to detect the presence of fatty liver in obese children by liver sonography and to assess its relationship to serum leptin, adiponectin, and the lipid profile.
Our study showed that fatty liver was dominant in male patients (60% in group I and in group II). This agreed with Yalniz et al. [13] who found that 67.6% of patients with fatty liver were male. In contrast, Kelley et al. [14] reported that male individuals are more likely to distribute excess body fat in the intra-abdominal compartment. The portal hypothesis states that the complications of obesity are attributable to accumulation of visceral adipose tissue in the mesentery and omentum. A majority of studies in adults demonstrate a relationship between the amount of visceral adipose tissue and the presence of hepaticsteatosis. However, this hypothesis has not yet been tested in the pediatric age range [14] . There was a highly significant difference between our studied groups as regards liver enzymes (ALT and aspartate aminotransferase), which were markedly elevated in group I. This agreed with Roberts [15] who said that mildly elevated levels of serum ALT may be found in children with NAFLD, with some having levels 10 times the normal.
In addition, Fishbein et al. [16] found that in obese children an elevated serum (ALT) is a strong predictor of fatty liver. An ALTZ40 U/l in obese adults with a BMI435 kg/m 2 is a strong independent risk factor for NASH.
In the absence of liver biopsy, presumed NAFLD is diagnosed by classical ultrasonographic hepatic appearances and/or by elevated serum (ALT) [17] .
Our study showed a highly significant difference between patients and controls as regards serum TG level (143.6 ± 30.8 vs. 93.2 ± 17.8 mg/dl), whereas there was no significant difference between them with regard to serum cholesterol level.
Kashyap et al. [18] proved that elevated TG concentrations in their cohort were strongly associated with severity of NAFLD and presence of NASH. Thus, the reciprocal relationship between TG and high-density lipoprotein cholesterol found in IR states is clearly relevant to the identification of NASH.
In obese children, IR is associated with plasma lipid alterations suggestive of both decreased adipose tissue lipolysis and hepatic b-oxidation and increased hepatic synthesis of TGs. Such a metabolic condition may facilitate fat storage and hinder weight loss [4] .
With regard to glucose and insulin status, our results showed that serum insulin and HOMA were significantly higher in group I than in group II. There was no significant difference between the two groups with regard to blood glucose level.
This was in contrast to the results obtained in the study by Radetti et al. [19] , who showed decreased insulin sensitivity in all of the obese children studied but no difference between children with NAFLD and those without NAFLD.
Moreover, Chan et al. [20] showed a positive correlation between IR markers and presumed NASH only in obese boys.
Nadeau et al. [21] reported a high prevalence of elevated ALT among children with type 2 diabetes mellitus, unrelated to age, BMI, and glycemic index. Thus, elevations in ALT may not only be a marker of liver injury and a surrogate for fatty liver disease but may also be an early indicator of diabetes [21] .
In contrast, Semple et al. [22] studied 41 patients with insulin receptor mutations. They found that despite higher plasma free fatty acid and glucose levels and massively increased plasma insulin levels, liver fat measurements were normal in those patients. Theoretically, this could be a result of either reduced hepatic lipogenesis or increased oxidation or excretion of liver TGs [22] .
Our results showed a significant difference between patients and controls in the mean leptin level (17.4 ± 3.66 vs. 14.1 ± 2.35, Po0.05).
This agreed with the results obtained by Licinio et al. [23] , who found a two-fold increase in serum leptin levels in normal weight children with fatty liver when compared with those without fatty liver. They noticed that, in obese patients, excessive food intake enhances leptin levels, resulting in decreased hypothalamic sensitivity and leptin resistance. Accordingly, in leptindeficient patients, leptin treatment was demonstrated to decrease appetite and increase weight loss.
Our study showed a significant decrease in height and increase in BMI in patients with fatty liver relative to the control group. Moreover, we also observed a significant positive correlation between leptin and BMI and a significant negative correlation between adiponectin and BMI in group I patients.
This agreed with a study conducted in overweight children and adolescents by Antunes et al. [24] . They showed that greater BMI was significantly and independently associated with increased serum leptin levels.
In addition, the study conducted by Xiao et al. [25] showed that the value of leptin was positively correlated with the values of fasting insulin level and BMI and that it was significantly negatively correlated with the insulin sensitivity index.
In their study, BMI was significantly positively correlated with the values of hypersensitive CRP (hsCRP), leptin, and fasting insulin level but was significantly negatively correlated with the insulin sensitivity index. There was a positive correlation between the value of hsCRP and those of fasting plasma glucose and fasting insulin level, and there was a negative correlation between the value of hsCRP and the insulin sensitivity index.
In contrast, Chalasani et al. [26] reported that serum leptin was not statistically different between 26 patients with biopsy-proven NAFLD and their age-matched, sexmatched, and BMI-matched controls. Furthermore, the serum leptin levels and the hepatic leptin receptor mRNA expression were similar in five patients with NASH and in five patients with simple steatosis [26] .
Nakao et al. [27] found that BMI, serum leptin levels, body fat ratio, and abdominal wall fat index were higher in steatotic patients. They concluded that the main determinant of serum leptin levels in obesity was total body fat and subcutaneous fat ratio rather than BMI.
Our results showed a low serum adiponectin level in group I compared with group II patients (10.58 ± 2.04 vs. 13.36 ± 1.8, Pr0.001). We found that adiponectin negatively correlated with serum cholesterol and TGs.
Another study in children demonstrated that adiponectin levels inversely correlated with obesity and IR and directly correlated with high-density lipoprotein levels [29] .
Hypoadiponectinemia was strongly associated with hepatic steatosis, as reported in adults [30] .
A recent clinical trial demonstrated that the marked increase in adiponectin after pioglitazone treatment was closely related to a decrease in hepatic fat content [31] .
Burgert et al. [32] hypothesized that a negative correlation between adiponectin and ALT did not emerge because of ALT being an imperfect biochemical surrogate marker for steatosis. In addition, they presumed that other factors (environmental and/or genetic) may contribute to ALT elevations beyond the presence of steatosis.
In contrast, Shin et al. [33] found that serum adiponectin level decreased and serum CRP level increased in obese children.
In the absence of liver biopsy, presumed NAFLD is diagnosed by classical ultrasonographic hepatic appearances and/or elevated serum ALT. Therefore, in pediatric practice, US is often used in assessing NAFLD and is helpful in identifying steatosis. However, its role in grading the degree of steatosis is limited [34] .
Our study showed a significant positive correlation between leptin and degree of steatosis and showed a significant negative correlation between adiponectin and degree of liver steatosis, as assessed by liver ultrasound.
This agreed with the study by Westerbacka et al. [35] , who studied fatty liver in adults. They observed a relationship between adiponectin deficiency and increased liver fat.
In addition, Targher et al. [36] stated that, in mild obesity, hypoadiponectinemia predicted the presence of hepatic steatosis on ultrasound examination.
Osawa and Mori [37] proved that the sensitivity and specificity of ultrasound are 89% and 93%, respectively, as a diagnostic tool for fatty liver and 89% and 77%, respectively, to detect liver fibrosis. Ultrasound has many drawbacks as a diagnostic tool because it is operator dependent, and in very obese children the subcutaneous fat can interfere with the scanning. Computed tomography is more specific but is expensive. US is slightly sensitive, simple, cheap, easily available, and requires no preparations. The echogenicity of the renal cortex can be altered by disease processes, making the comparison less reliable.
Conclusion
Thus, in this study we conclude that (1) Prevention of obesity and identification of children with an increased risk of hepatic steatosis are important steps in preventing irreversible liver damage.
(2) US is a useful noninvasive tool in identifying and monitoring the process.
